3-Pyridyl-1-azabicycloalkanderivater til forhindring og behandling af afvigelser i centralnervesystemet
Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder,...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | dan |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CALDWELL, WILLIAM, SCOTT CROOKS, PETER, ANTHONY BENCHERIF, MEROUANE BHATTI, BALWINDER, SINGH DEO, NIRANJAN, MADHUKAR DULL, GARY, MAURICE LIPPIELLO, PATRICK, MICHAEL RAVARD, ALAIN |
| description | Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia) are treated by administering an endo or exo form of a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a 1-aza-2-(3-pyridyl)bicyclo[2.2.2] octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK0994875TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK0994875TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK0994875TT33</originalsourceid><addsrcrecordid>eNqNi00KwjAQhbtxIeod4gECShXt2h8ENy66L9N2kg6OSZmEQjy9ETyA8ODx-L43L2ypH0moT6y3Gt7QUpc69sBPcD0KTRBRVCRWxstArhdyVnmrWhyywd8FJmciixyyS6pDFwXYoUwYUoj4wrgsZgYyX_16Uayvl_p00zj6BsMI-YSxOd83VbU7HvZ1XZb_OB8K30E8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3-Pyridyl-1-azabicycloalkanderivater til forhindring og behandling af afvigelser i centralnervesystemet</title><source>esp@cenet</source><creator>CALDWELL, WILLIAM, SCOTT ; CROOKS, PETER, ANTHONY ; BENCHERIF, MEROUANE ; BHATTI, BALWINDER, SINGH ; DEO, NIRANJAN, MADHUKAR ; DULL, GARY, MAURICE ; LIPPIELLO, PATRICK, MICHAEL ; RAVARD, ALAIN</creator><creatorcontrib>CALDWELL, WILLIAM, SCOTT ; CROOKS, PETER, ANTHONY ; BENCHERIF, MEROUANE ; BHATTI, BALWINDER, SINGH ; DEO, NIRANJAN, MADHUKAR ; DULL, GARY, MAURICE ; LIPPIELLO, PATRICK, MICHAEL ; RAVARD, ALAIN</creatorcontrib><description>Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia) are treated by administering an endo or exo form of a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a 1-aza-2-(3-pyridyl)bicyclo[2.2.2] octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane.</description><edition>7</edition><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040621&DB=EPODOC&CC=DK&NR=0994875T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040621&DB=EPODOC&CC=DK&NR=0994875T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CALDWELL, WILLIAM, SCOTT</creatorcontrib><creatorcontrib>CROOKS, PETER, ANTHONY</creatorcontrib><creatorcontrib>BENCHERIF, MEROUANE</creatorcontrib><creatorcontrib>BHATTI, BALWINDER, SINGH</creatorcontrib><creatorcontrib>DEO, NIRANJAN, MADHUKAR</creatorcontrib><creatorcontrib>DULL, GARY, MAURICE</creatorcontrib><creatorcontrib>LIPPIELLO, PATRICK, MICHAEL</creatorcontrib><creatorcontrib>RAVARD, ALAIN</creatorcontrib><title>3-Pyridyl-1-azabicycloalkanderivater til forhindring og behandling af afvigelser i centralnervesystemet</title><description>Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia) are treated by administering an endo or exo form of a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a 1-aza-2-(3-pyridyl)bicyclo[2.2.2] octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi00KwjAQhbtxIeod4gECShXt2h8ENy66L9N2kg6OSZmEQjy9ETyA8ODx-L43L2ypH0moT6y3Gt7QUpc69sBPcD0KTRBRVCRWxstArhdyVnmrWhyywd8FJmciixyyS6pDFwXYoUwYUoj4wrgsZgYyX_16Uayvl_p00zj6BsMI-YSxOd83VbU7HvZ1XZb_OB8K30E8</recordid><startdate>20040621</startdate><enddate>20040621</enddate><creator>CALDWELL, WILLIAM, SCOTT</creator><creator>CROOKS, PETER, ANTHONY</creator><creator>BENCHERIF, MEROUANE</creator><creator>BHATTI, BALWINDER, SINGH</creator><creator>DEO, NIRANJAN, MADHUKAR</creator><creator>DULL, GARY, MAURICE</creator><creator>LIPPIELLO, PATRICK, MICHAEL</creator><creator>RAVARD, ALAIN</creator><scope>EVB</scope></search><sort><creationdate>20040621</creationdate><title>3-Pyridyl-1-azabicycloalkanderivater til forhindring og behandling af afvigelser i centralnervesystemet</title><author>CALDWELL, WILLIAM, SCOTT ; CROOKS, PETER, ANTHONY ; BENCHERIF, MEROUANE ; BHATTI, BALWINDER, SINGH ; DEO, NIRANJAN, MADHUKAR ; DULL, GARY, MAURICE ; LIPPIELLO, PATRICK, MICHAEL ; RAVARD, ALAIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK0994875TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CALDWELL, WILLIAM, SCOTT</creatorcontrib><creatorcontrib>CROOKS, PETER, ANTHONY</creatorcontrib><creatorcontrib>BENCHERIF, MEROUANE</creatorcontrib><creatorcontrib>BHATTI, BALWINDER, SINGH</creatorcontrib><creatorcontrib>DEO, NIRANJAN, MADHUKAR</creatorcontrib><creatorcontrib>DULL, GARY, MAURICE</creatorcontrib><creatorcontrib>LIPPIELLO, PATRICK, MICHAEL</creatorcontrib><creatorcontrib>RAVARD, ALAIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CALDWELL, WILLIAM, SCOTT</au><au>CROOKS, PETER, ANTHONY</au><au>BENCHERIF, MEROUANE</au><au>BHATTI, BALWINDER, SINGH</au><au>DEO, NIRANJAN, MADHUKAR</au><au>DULL, GARY, MAURICE</au><au>LIPPIELLO, PATRICK, MICHAEL</au><au>RAVARD, ALAIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3-Pyridyl-1-azabicycloalkanderivater til forhindring og behandling af afvigelser i centralnervesystemet</title><date>2004-06-21</date><risdate>2004</risdate><abstract>Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia) are treated by administering an endo or exo form of a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a 1-aza-2-(3-pyridyl)bicyclo[2.2.2] octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | dan |
| recordid | cdi_epo_espacenet_DK0994875TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 3-Pyridyl-1-azabicycloalkanderivater til forhindring og behandling af afvigelser i centralnervesystemet |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A21%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CALDWELL,%20WILLIAM,%20SCOTT&rft.date=2004-06-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK0994875TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |